Schedule 13G filing

Empery Asset Management, LP cut its Annovis Bio, Inc. (ANVS) stake below 5%

Schedule 13G · Filed Oct 15, 2026

Empery Asset Management, LP reported owning 5% of Annovis Bio, Inc. (ANVS) (2,241,537 shares) in a Schedule 13G filed Oct 15, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Exited

Annovis Bio, Inc.

Stake

5% stake

More ANVS insider and Congress trades

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.